Neumora Therapeutics Shares Are Trading Higher. B of A Securities Maintained a Buy Rating on the Stock.

Benzinga04:49

B of A Securities Maintains Buy on Neumora Therapeutics, Lowers Price Target to $7

BenzingaJan 6 19:42 · Ratings

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA) and Idexx Laboratories (IDXX)

TipRanksJan 6 08:10 · Ratings

Trending Stocks as Wall Street Steps Into First Days of 2025 With Cautiousness

Seeking AlphaJan 5 01:09

Sector Update: Health Care Stocks Higher Friday Afternoon

MT NewswiresJan 4 02:57

Neumora Therapeutics Up Over 16%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk

Dow JonesJan 4 00:05